Financhill
Buy
61

BLK Quote, Financials, Valuation and Earnings

Last price:
$988.50
Seasonality move :
3.23%
Day range:
$984.99 - $991.00
52-week range:
$752.30 - $1,084.22
Dividend yield:
2.09%
P/E ratio:
23.86x
P/S ratio:
7.18x
P/B ratio:
3.17x
Volume:
495.8K
Avg. volume:
614.9K
1-year change:
25.94%
Market cap:
$152.2B
Revenue:
$20.4B
EPS (TTM):
$41.16

Earnings Data

Next earnings date for BLK
Jul 15
2025
Most recent earnings per share
$9.64
Missed by $0.49
(Apr 11/2025)
Consensus Estimate
$10.13
(Apr 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BLK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/15/2025 Q2 $5.4B -- -- $10.57 --
04/11/2025 Q1 $5.3B $5.3B $9.64 $10.13 -$0.49
01/15/2025 Q4 $5.6B $5.7B $10.63 $11.22 -$0.59
10/11/2024 Q3 $4.9B $5.2B $10.90 $10.31 $0.59
07/15/2024 Q2 $4.8B $4.8B $9.99 $9.96 $0.03
04/12/2024 Q1 $4.7B $4.7B $10.48 $9.39 $1.09
01/12/2024 Q4 $4.6B $4.6B $9.15 $8.88 $0.27
10/13/2023 Q3 $4.5B $4.5B $10.66 $8.34 $2.32
07/14/2023 Q2 $4.4B $4.5B $9.06 $8.47 $0.59
04/14/2023 Q1 $4.2B $4.2B $7.64 $7.73 -$0.09
01/13/2023 Q4 -- $4.3B $8.29 -- --
10/13/2022 Q3 -- $4.3B $9.25 -- --
07/15/2022 Q2 -- $4.5B $7.06 -- --
04/13/2022 Q1 -- $4.7B $9.35 -- --
01/14/2022 Q4 -- $5.1B $10.59 -- --
10/13/2021 Q3 -- $5.1B $10.85 -- --
07/14/2021 Q2 -- $4.8B $8.88 -- --
04/15/2021 Q1 -- $4.4B $7.74 -- --
01/14/2021 Q4 -- $4.5B $9.98 -- --
10/13/2020 Q3 -- $4.4B $8.83 -- --
07/17/2020 Q2 -- $3.6B $7.82 -- --
04/16/2020 Q1 -- $3.7B $5.13 -- --
01/15/2020 Q4 -- $4B $8.26 -- --
10/15/2019 Q3 -- $3.7B $7.12 -- --
07/19/2019 Q2 -- $3.5B $6.38 -- --
04/16/2019 Q1 -- $3.3B $6.58 -- --
01/16/2019 Q4 -- $3.4B $5.76 -- --
10/16/2018 Q3 -- $3.6B $7.51 -- --
07/16/2018 Q2 -- $3.6B $6.59 -- --
04/12/2018 Q1 -- $3.6B $6.65 -- --
01/12/2018 Q4 -- $3.8B $13.95 -- --
10/11/2017 Q3 -- $3.5B $5.74 -- --
07/17/2017 Q2 -- $3.2B $5.18 -- --
04/19/2017 Q1 -- $3.1B $5.19 -- --
01/13/2017 Q4 -- $4B $5.11 -- --
10/18/2016 Q3 -- $2.8B $5.24 -- --
07/14/2016 Q2 -- $2.8B $4.71 -- --
04/14/2016 Q1 -- $2.6B $3.90 -- --
01/15/2016 Q4 -- $2.9B $5.09 -- --
10/14/2015 Q3 -- $2.9B $4.98 -- --
07/15/2015 Q2 -- $2.9B $4.82 -- --

BlackRock Earnings Questions

  • How Much did BlackRock Generate in Revenue Last Quarter?

    BlackRock reported $5.3B worth of top line sales in its most recent quarter.

  • Did BlackRock Beat Earnings Last Quarter?

    BlackRock announced earnings per share of $9.64 which represents a miss of analyst forecast a $10.13 per share.

  • Is BlackRock Profitable?

    BlackRock reported $2.5B that represents $16.13 per share over the last quarter.

  • What is the Analyst Consensus for BlackRock EPS Next Year?

    BlackRock's earnings are forecast to grow from $42.01 per share to $43.00 per share next year representing an increase of 6.96%.

  • When is BlackRock's Earnings Date?

    BlackRock's next earnings date is July 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
CTRN alert for Jun 5

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock